IO Biotech Announces Presentation of New Data from MM1636 Phase 1/2 Clinical Trial Presented at 2022 AACR Annual Meeting
Source:
Nasdaq GlobeNewswire
/
08 Apr 2022 15:15:00 America/Chicago
N/A
Share on,